Syn­thego adds $100M from RA, Welling­ton, 8VC in pur­suit of 'vir­tu­al­iz­ing bi­ol­o­gy'

The Pe­ter Thiel-backed, Jen­nifer Doud­na-ad­vised, SpaceX en­gi­neer-found­ed CRISPR plat­form com­pa­ny just added a new mega-round.

Syn­thego an­nounced $100 mil­lion in Se­ries D fund­ing led by Welling­ton Man­age­ment, RA Cap­i­tal Man­age­ment and 8VC. The com­pa­ny’s sec­ond $100 mil­lion-plus round since 2018, the new cash will help Syn­thego ad­vance its plat­form of CRISPR as­says, screens and en­gi­neered cell lines.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER